Global Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2023-2027

Report ID: 949977 | Published Date: Oct 2024 | No. of Page: 109 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Monotherapy
        1.2.3 Combination Therapy
    1.3 Market by Application
        1.3.1 Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Medical Research Institution
        1.3.3 Hospital and Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Synthetic Lethality-based Drugs and Targets Market Perspective (2016-2027)
    2.2 Synthetic Lethality-based Drugs and Targets Growth Trends by Regions
        2.2.1 Synthetic Lethality-based Drugs and Targets Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Synthetic Lethality-based Drugs and Targets Historic Market Share by Regions (2016-2021)
        2.2.3 Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2022-2027)
    2.3 Synthetic Lethality-based Drugs and Targets Industry Dynamic
        2.3.1 Synthetic Lethality-based Drugs and Targets Market Trends
        2.3.2 Synthetic Lethality-based Drugs and Targets Market Drivers
        2.3.3 Synthetic Lethality-based Drugs and Targets Market Challenges
        2.3.4 Synthetic Lethality-based Drugs and Targets Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue
        3.1.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue (2016-2021)
        3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Players (2016-2021)
    3.2 Global Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Synthetic Lethality-based Drugs and Targets Revenue
    3.4 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio
        3.4.1 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Synthetic Lethality-based Drugs and Targets Revenue in 2020
    3.5 Synthetic Lethality-based Drugs and Targets Key Players Head office and Area Served
    3.6 Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
    3.7 Date of Enter into Synthetic Lethality-based Drugs and Targets Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Synthetic Lethality-based Drugs and Targets Breakdown Data by Type
    4.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Type (2016-2021)
    4.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2022-2027)

5 Synthetic Lethality-based Drugs and Targets Breakdown Data by Application
    5.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Application (2016-2021)
    5.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
    6.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type
        6.2.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
        6.2.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
        6.2.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
    6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application
        6.3.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
        6.3.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
        6.3.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
    6.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Country
        6.4.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
        6.4.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
    7.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type
        7.2.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
        7.2.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
        7.2.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
    7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application
        7.3.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
        7.3.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
        7.3.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
    7.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country
        7.4.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
        7.4.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
    8.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type
        8.2.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
    8.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application
        8.3.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
    8.4 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region
        8.4.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
    9.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type
        9.2.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
        9.2.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
        9.2.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
    9.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application
        9.3.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
        9.3.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
        9.3.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
    9.4 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country
        9.4.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
        9.4.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
    10.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type
        10.2.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
    10.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application
        10.3.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
    10.4 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country
        10.4.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Introduction
        11.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.1.5 AbbVie Recent Development
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Details
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Introduction
        11.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.2.5 AstraZeneca Recent Development
    11.3 BeiGene
        11.3.1 BeiGene Company Details
        11.3.2 BeiGene Business Overview
        11.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Introduction
        11.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.3.5 BeiGene Recent Development
    11.4 Clovis Oncology
        11.4.1 Clovis Oncology Company Details
        11.4.2 Clovis Oncology Business Overview
        11.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Introduction
        11.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.4.5 Clovis Oncology Recent Development
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Details
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Introduction
        11.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.5.5 GlaxoSmithKline Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Introduction
        11.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.6.5 Pfizer Recent Development
    11.7 AtlasMedx
        11.7.1 AtlasMedx Company Details
        11.7.2 AtlasMedx Business Overview
        11.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Introduction
        11.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.7.5 AtlasMedx Recent Development
    11.8 Chordia Therapeutics
        11.8.1 Chordia Therapeutics Company Details
        11.8.2 Chordia Therapeutics Business Overview
        11.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
        11.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.8.5 Chordia Therapeutics Recent Development
    11.9 IDEAYA Biosciences
        11.9.1 IDEAYA Biosciences Company Details
        11.9.2 IDEAYA Biosciences Business Overview
        11.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Introduction
        11.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.9.5 IDEAYA Biosciences Recent Development
    11.10 Mission Therapeutics
        11.10.1 Mission Therapeutics Company Details
        11.10.2 Mission Therapeutics Business Overview
        11.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
        11.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.10.5 Mission Therapeutics Recent Development
    11.11 Repare Therapeutics
        11.11.1 Repare Therapeutics Company Details
        11.11.2 Repare Therapeutics Business Overview
        11.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
        11.11.4 Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.11.5 Repare Therapeutics Recent Development
    11.12 Sierra Oncology
        11.12.1 Sierra Oncology Company Details
        11.12.2 Sierra Oncology Business Overview
        11.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Introduction
        11.12.4 Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.12.5 Sierra Oncology Recent Development
    11.13 SyntheX Labs
        11.13.1 SyntheX Labs Company Details
        11.13.2 SyntheX Labs Business Overview
        11.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Introduction
        11.13.4 SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
        11.13.5 SyntheX Labs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Monotherapy
    Table 3. Key Players of Combination Therapy
    Table 4. Global Synthetic Lethality-based Drugs and Targets Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2016-2021)
    Table 8. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2022-2027)
    Table 10. Synthetic Lethality-based Drugs and Targets Market Trends
    Table 11. Synthetic Lethality-based Drugs and Targets Market Drivers
    Table 12. Synthetic Lethality-based Drugs and Targets Market Challenges
    Table 13. Synthetic Lethality-based Drugs and Targets Market Restraints
    Table 14. Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Synthetic Lethality-based Drugs and Targets Market Share by Players (2016-2021)
    Table 16. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2020)
    Table 17. Ranking of Global Top Synthetic Lethality-based Drugs and Targets Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
    Table 21. Date of Enter into Synthetic Lethality-based Drugs and Targets Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2016-2021)
    Table 25. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Synthetic Lethality-based Drugs and Targets Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2016-2021)
    Table 29. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. AbbVie Company Details
    Table 62. AbbVie Business Overview
    Table 63. AbbVie Synthetic Lethality-based Drugs and Targets Product
    Table 64. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 65. AbbVie Recent Development
    Table 66. AstraZeneca Company Details
    Table 67. AstraZeneca Business Overview
    Table 68. AstraZeneca Synthetic Lethality-based Drugs and Targets Product
    Table 69. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 70. AstraZeneca Recent Development
    Table 71. BeiGene Company Details
    Table 72. BeiGene Business Overview
    Table 73. BeiGene Synthetic Lethality-based Drugs and Targets Product
    Table 74. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 75. BeiGene Recent Development
    Table 76. Clovis Oncology Company Details
    Table 77. Clovis Oncology Business Overview
    Table 78. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product
    Table 79. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 80. Clovis Oncology Recent Development
    Table 81. GlaxoSmithKline Company Details
    Table 82. GlaxoSmithKline Business Overview
    Table 83. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product
    Table 84. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 85. GlaxoSmithKline Recent Development
    Table 86. Pfizer Company Details
    Table 87. Pfizer Business Overview
    Table 88. Pfizer Synthetic Lethality-based Drugs and Targets Product
    Table 89. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 90. Pfizer Recent Development
    Table 91. AtlasMedx Company Details
    Table 92. AtlasMedx Business Overview
    Table 93. AtlasMedx Synthetic Lethality-based Drugs and Targets Product
    Table 94. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 95. AtlasMedx Recent Development
    Table 96. Chordia Therapeutics Company Details
    Table 97. Chordia Therapeutics Business Overview
    Table 98. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 99. Chordia Therapeutics Recent Development
    Table 100. IDEAYA Biosciences Company Details
    Table 101. IDEAYA Biosciences Business Overview
    Table 102. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product
    Table 103. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 104. IDEAYA Biosciences Recent Development
    Table 105. Mission Therapeutics Company Details
    Table 106. Mission Therapeutics Business Overview
    Table 107. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 108. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 109. Mission Therapeutics Recent Development
    Table 110. Repare Therapeutics Company Details
    Table 111. Repare Therapeutics Business Overview
    Table 112. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 113. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 114. Repare Therapeutics Recent Development
    Table 115. Sierra Oncology Company Details
    Table 116. Sierra Oncology Business Overview
    Table 117. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product
    Table 118. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 119. Sierra Oncology Recent Development
    Table 120. SyntheX Labs Company Details
    Table 121. SyntheX Labs Business Overview
    Table 122. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product
    Table 123. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
    Table 124. SyntheX Labs Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Synthetic Lethality-based Drugs and Targets Market Share by Type: 2020 VS 2027
    Figure 2. Monotherapy Features
    Figure 3. Combination Therapy Features
    Figure 4. Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2020 VS 2027
    Figure 5. Medical Research Institution Case Studies
    Figure 6. Hospital and Clinic Case Studies
    Figure 7. Other Case Studies
    Figure 8. Synthetic Lethality-based Drugs and Targets Report Years Considered
    Figure 9. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions: 2020 VS 2027
    Figure 12. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2022-2027)
    Figure 13. Global Synthetic Lethality-based Drugs and Targets Market Share by Players in 2020
    Figure 14. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2020
    Figure 16. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2016-2021)
    Figure 17. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2022-2027)
    Figure 18. North America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
    Figure 20. North America Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
    Figure 21. North America Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
    Figure 22. United States Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
    Figure 26. Europe Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
    Figure 27. Europe Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
    Figure 28. Germany Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Region (2016-2027)
    Figure 38. China Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
    Figure 46. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
    Figure 47. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
    Figure 48. Mexico Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
    Figure 54. Turkey Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 58. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 59. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 60. Clovis Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 62. Pfizer Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 63. AtlasMedx Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 64. Chordia Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 65. IDEAYA Biosciences Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 66. Mission Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 67. Repare Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 68. Sierra Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 69. SyntheX Labs Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
AstraZeneca
BeiGene
Clovis Oncology
GlaxoSmithKline
Pfizer
AtlasMedx
Chordia Therapeutics
IDEAYA Biosciences
Mission Therapeutics
Repare Therapeutics
Sierra Oncology
SyntheX Labs
Frequently Asked Questions
Synthetic Lethality-based Drugs and Targets report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Synthetic Lethality-based Drugs and Targets report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Synthetic Lethality-based Drugs and Targets report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports